Member Info for imac1

Simple larger overall market economics causing the drop due to the US unemployment figures being worse than expected.
18 more trading days maximum before news not long have a great weekend all invested ;-)

The more i read the more i revise my Sp predictions to the upside....!!!
The global irritable bowel syndrome treatment market size was valued at USD 1.5 billion in 2018 and is anticipated to exhibit a CAGR of 10.1% over the forecast period. Rising prevalence of target disease, coupled with increasing uptake of drugs for the same, is driving the market.
The market mostly remains underserved, with a considerable number of opportunities for pharmaceutical companies to address several unmet needs in this therapy area. There are a few promising products currently under clinical trials, which can further accelerate growth. Product sales are projected to grow significantly over the forecast period, mainly due to increasing prevalent population and commercialization of novel drugs to treat Constipation-predominant irritable bowel syndrome (IBS).
Irritable bowel syndrome is one of the most common functional gastrointestinal disorders, with an estimated global prevalence rate of 10-15%. According to the International Foundation for Gastrointestinal Disorders (IFFGD) in 2016, it was estimated that IBS affects around 25-45 million in the U.S. About 2 in 3 IBS patients are female and most people with this condition are under the age of 50.
Source: https://www.grandviewresearch.com/industry-analysis/irritable-bowel-syndrome-ibs-treatment-market#:~:text=The%20global%20irritable%20bowel%20syndrome,same%2C%20is%20driving%20the%20market.

Agree can see a nice push towards a close around high 130s at least.
Way to risky to hold out for a better price, I remember saying the same thing about SNG on the Friday with news imminent then bang Monday RNS and it opened at double and went on to 5 bag that day.

Another £50k just bought up on A trades

We have had a nice consolidation phase over the last 2 days and I can now only see this rising from here on in. We only have 18 trading days left until IBS results and possibly Covid initial results also.
L2 currently showing us at 133-134p :-)

Upcoming News and SP for Positive results
Clinical Phase II Trial Results for Blautix IBS - SP 500-600p
Clinical Phase II Trail Results for MRx-4DP0004 – SP Potential 300-400p
If both results are positive, then we could be looking at a SP of 750p- 1000p

Ophidian,

News also due on our Covid 19 Phase II trial with MRx-4DP0004.
Most on here haven't given any thought or discussion to this trial but doing some research it seems far more promising than its being given credit for and so the experts think also.

4D's Chief Scientific Officer, Alex Stevenson, commented:
If MRx-4DP0004 is successful in this study it would represent a highly significant breakthrough in the global fight against the novel coronavirus pandemic."

Dr. Dinesh Saralaya (Consultant Respiratory Physician and Associate Director of Research at Bradford Teaching Hospitals NHS Foundation Trust, and the National Institute for Health Research's (NIHR) Clinical Lead for Respiratory industry studies), commented:
"As well as its appropriate mechanism of action, the highly favourable safety profile of MRx-4DP0004 makes it a particularly attractive candidate for COVID-19 patients, and may potentially allow us to prevent or delay their progression to requiring ventilation and intensive care."

Looking good on L2 for a move up now just gone green on L2 ask moved up to 133.50 buys coming in.

Why anyone would want to sit this out over the weekend or try and make a quick buck on any other shares in today's market is beyond me. News could land any day now on our IBS or Covid 19 Phase II trials. The SP could open at 2 or 3 bags if the new is good and once again Pis will be crying into there cornflakes saying should have bought. If we are to believe what some of us have read on Reddit a poster on there said this "I've just completed the same trial. My IBS-D was caused by IV antibiotics while in hospital. After completing the blautix medication course my IBS symptoms have completely disappeared. I mean complete recovery, no joke. I was a strict low FODMAP diet for several months, but now I am eating wheat and onion and garlic again without issue. Fantastic result, I hope it lasts!"

Not a great day on the markets overall looks like they tried to mug a few early doors but SP held strong and if anything bid moving back up and we may turn blue soon. :-)

Got too keep them going wouldn’t be an LSE and AIM chat board otherwise Wolves ... haha

John it’s worth £4+ right now just on the portfolio of products I’ve been saying it for a couple of weeks now. We will rerate to that easily on good IBS or Covid results both and we are talking £8+

Joey that's pure speculation and punt money going into PYC now off the back of the rise here.

Fully backing up my statement that on good news this will be worth north of £4 and that is just taking into account what we have going on at the moment with no value attribution to a successful IBS or Covid Phase II.
Welcome to 4D RK great write up of current and future clinical trials. Serious value to be added to this company both short and long term if we are not bought out before then.
If we can get our milestone payments then funding will not be an issue and i believe at least 2/3 products will go into Phase III and on wards.

Its not though is it M.oz im watching L2

Im in VAl also as I said only a few days ago Mazik. I just get annoyed with there has been a leak blah blah when no one can prove it. I checked all social media its a load of rubbish.
As for Potential well yes its about time VAL is worth many many multiples of the current SP on good Phase II news.
GLTAH

Nothing o twitter has someone posted and removed within minutes or is all this leak chat just a load of pump and dump day traders...!!!!

So Zak says it’s plausible for 1.80 over the next few trading sessions. Remember folks that’s without news. If good news drops then this will be £4+ Don’t say you weren’t told.

Thanks for the ADVDN repost which goes to back up what I’ve been saying. People have taken their eye of the ball with the Covid 19 Phase II trial also due results for end of Sept.
Here is what the experts had to say about it.
4D's Chief Scientific Officer, Alex Stevenson, commented:
If MRx-4DP0004 is successful in this study it would represent a highly significant breakthrough in the global fight against the novel coronavirus pandemic."

Dr. Dinesh Saralaya (Consultant Respiratory Physician and Associate Director of Research at Bradford Teaching Hospitals NHS Foundation Trust, and the National Institute for Health Research's (NIHR) Clinical Lead for Respiratory industry studies), commented:
"As well as its appropriate mechanism of action, the highly favourable safety profile of MRx-4DP0004 makes it a particularly attractive candidate for COVID-19 patients, and may potentially allow us to prevent or delay their progression to requiring ventilation and intensive care."

Haha yeah and failed now they will be buying in and using their institutions to eventually buy DDDD out with a Big US Pharma takeover bid. So this time round I say bring it on hah